In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien Runs Familiar But Different Plays to Build Vascular Franchise

Executive Summary

Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.
Advertisement

Related Content

Device M&A Poised For A Strong Year
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2010
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2010
ev3 Expands Neurovascular Division With Acquisition Of Chestnut
Covidien Set to Compete in Vascular Business
Spun Out, Covidien Rolls On
FoxHollow Integration Problems Plague ev3 In First Quarter
ev3: The Virtues of Focus
Ev3 Goes Global
What Makes Tyco Run?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel